↓ Skip to main content

Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

Overview of attention for article published in Critical Care, December 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
34 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance
Published in
Critical Care, December 2016
DOI 10.1186/s13054-016-1549-1
Pubmed ID
Authors

Steven M. Opal

Abstract

The emergence of multi-drug resistant (MDR) microbial pathogens threatens the very foundation upon which standard antibacterial chemotherapy is based. We must consider non-antibiotic solutions to manage invasive bacterial infections. Transition from antibiotics to non-traditional treatments poses real clinical challenges that will not be easy to solve. Antibiotics will continue to reliably treat some infections (e.g., group A streptococci and Treponema pallidum) but will likely need adjuvant therapies or will need to be replaced for many bacterial infections in the future.

Twitter Demographics

The data shown below were collected from the profiles of 34 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 16%
Student > Bachelor 18 16%
Researcher 14 13%
Student > Ph. D. Student 13 12%
Professor 6 5%
Other 18 16%
Unknown 23 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 16%
Medicine and Dentistry 16 15%
Agricultural and Biological Sciences 15 14%
Immunology and Microbiology 12 11%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Other 16 15%
Unknown 26 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2018.
All research outputs
#1,183,184
of 19,776,983 outputs
Outputs from Critical Care
#1,090
of 5,626 outputs
Outputs of similar age
#32,561
of 411,226 outputs
Outputs of similar age from Critical Care
#116
of 244 outputs
Altmetric has tracked 19,776,983 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,626 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 411,226 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 244 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.